Literature DB >> 20096225

Impact of mucosal eosinophilia and nasal polyposis on quality-of-life outcomes after sinus surgery.

Zachary M Soler1, David Sauer, Jess Mace, Timothy L Smith.   

Abstract

OBJECTIVE: Assess whether the presence of mucosal eosinophilia correlates with surgical outcomes in patients with chronic rhinosinusitis. STUDY
DESIGN: Prospective cohort.
SETTING: Tertiary medical center. SUBJECTS AND METHODS: Adult patients with chronic rhinosinusitis were prospectively enrolled, and demographic data and medical comorbidities were recorded. Preoperative quality of life (QOL) was measured by the Chronic Sinusitis Survey (CSS), Rhinosinusitis Disability Index (RSDI), and Short Form-36 General Health Survey (SF-36). Sinus mucosal specimens were collected at the time of surgery and the degree of eosinophilia quantified. Postoperative QOL was measured, and differences in QOL improvement were compared between those with and without eosinophilia.
RESULTS: A total of 102 patients had both histopathological and QOL outcome data available for review. Follow-up averaged 16.5 months. Patients with eosinophilia showed significantly less improvement in the RSDI total (17.9 vs 25.0; P = 0.044), RSDI functional (5.7 vs 8.8; general health subscale; P = 0.018), CSS medication (3.6 vs 17.3; P = 0.013), SF-36 general health (0.6 vs 9.6; P = 0.008), SF-36 physical role (16.1 vs 34.7; P = 0.036), and SF-36 vitality (11.9 vs 21.2; P = 0.034) scales than those without eosinophilia. The greatest improvement in QOL was seen in patients without eosinophilia or polyps, with the least improvement seen in those with eosinophilia but without polyps.
CONCLUSION: The presence of mucosal eosinophilia at the time of surgery consistently predicted less improvement in both disease-specific and general QOL compared with patients without eosinophilia. The impact of eosinophilia on outcomes was greatest for patients without nasal polyposis, a group that demonstrated the least improvement in QOL measures.

Entities:  

Mesh:

Year:  2009        PMID: 20096225      PMCID: PMC2811855          DOI: 10.1016/j.otohns.2009.10.005

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  17 in total

1.  Predictive factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis.

Authors:  Timothy L Smith; Sabrina Mendolia-Loffredo; Todd A Loehrl; Rodney Sparapani; Purushottam W Laud; Ann B Nattinger
Journal:  Laryngoscope       Date:  2005-12       Impact factor: 3.325

2.  The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  J E Ware; M Kosinski; B Gandek; N K Aaronson; G Apolone; P Bech; J Brazier; M Bullinger; S Kaasa; A Leplège; L Prieto; M Sullivan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  Sex differences in outcomes of sinus surgery.

Authors:  Sabrina Mendolia-Loffredo; Purushottam W Laud; Rodney Sparapani; Todd A Loehrl; Timothy L Smith
Journal:  Laryngoscope       Date:  2006-07       Impact factor: 3.325

4.  A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease.

Authors:  Kathleen W Wyrwich; William M Tierney; Ajit N Babu; Kurt Kroenke; Fredric D Wolinsky
Journal:  Health Serv Res       Date:  2005-04       Impact factor: 3.402

Review 5.  Staging for rhinosinusitis.

Authors:  V J Lund; D W Kennedy
Journal:  Otolaryngol Head Neck Surg       Date:  1997-09       Impact factor: 5.591

6.  Clinical practice guideline: adult sinusitis.

Authors:  Richard M Rosenfeld; David Andes; Neil Bhattacharyya; Dickson Cheung; Steven Eisenberg; Theodore G Ganiats; Andrea Gelzer; Daniel Hamilos; Richard C Haydon; Patricia A Hudgins; Stacie Jones; Helene J Krouse; Lawrence H Lee; Martin C Mahoney; Bradley F Marple; Col John P Mitchell; Robert Nathan; Richard N Shiffman; Timothy L Smith; David L Witsell
Journal:  Otolaryngol Head Neck Surg       Date:  2007-09       Impact factor: 3.497

Review 7.  Rhinosinusitis: Establishing definitions for clinical research and patient care.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich
Journal:  Otolaryngol Head Neck Surg       Date:  2004-12       Impact factor: 3.497

8.  Impact of aspirin intolerance on outcomes of sinus surgery.

Authors:  Jamie L Robinson; Susan Griest; Kenneth E James; Timothy L Smith
Journal:  Laryngoscope       Date:  2007-05       Impact factor: 3.325

9.  Relationship between clinical measures and histopathologic findings in chronic rhinosinusitis.

Authors:  Zachary M Soler; David A Sauer; Jess Mace; Timothy L Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2009-10       Impact factor: 3.497

10.  The development of the Rhinosinusitis Disability Index.

Authors:  M S Benninger; B A Senior
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-11
View more
  59 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

Review 2.  Eosinophil ETosis and DNA Traps: a New Look at Eosinophilic Inflammation.

Authors:  Shigeharu Ueki; Takahiro Tokunaga; Shigeharu Fujieda; Kohei Honda; Makoto Hirokawa; Lisa A Spencer; Peter F Weller
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 3.  Chronic Rhinosinusitis without Nasal Polyps.

Authors:  Seong Ho Cho; Dae Woo Kim; Philippe Gevaert
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jul-Aug

4.  Predictors of quality of life outcomes in chronic rhinosinusitis after sinus surgery.

Authors:  Michael Katotomichelakis; Efthimios Simopoulos; Gregory Tripsianis; Dimitrios Balatsouras; Gerasimos Danielides; Christos Kourousis; Miltos Livaditis; Vassilios Danielides
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-11       Impact factor: 2.503

5.  Mucus T helper 2 biomarkers predict chronic rhinosinusitis disease severity and prior surgical intervention.

Authors:  Justin H Turner; Ping Li; Rakesh K Chandra
Journal:  Int Forum Allergy Rhinol       Date:  2018-06-08       Impact factor: 3.858

Review 6.  Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.

Authors:  Mauricio López-Chacón; Joaquim Mullol; Laura Pujols
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

7.  Surgical treatment for nasal polyposis: predictors of outcome.

Authors:  Marko Velimir Grgić; Hrvoje Ćupić; Livije Kalogjera; Tomislav Baudoin
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-30       Impact factor: 2.503

8.  A prospective analysis evaluating tissue biopsy location and its clinical relevance in chronic rhinosinusitis with nasal polyps.

Authors:  Ava R Weibman; Julia He Huang; Whitney W Stevens; Lydia A Suh; Caroline P E Price; Alcina K Lidder; David B Conley; Kevin C Welch; Stephanie Shintani-Smith; Anju T Peters; Leslie C Grammer; Atsushi Kato; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  Int Forum Allergy Rhinol       Date:  2017-09-01       Impact factor: 3.858

9.  Using preoperative unsupervised cluster analysis of chronic rhinosinusitis to inform patient decision and endoscopic sinus surgery outcome.

Authors:  Choaib Adnane; Taoufik Adouly; Amine Khallouk; Sami Rouadi; Redallah Abada; Mohamed Roubal; Mohamed Mahtar
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-24       Impact factor: 2.503

Review 10.  Outcomes After Frontal Sinus Surgery: An Evidence-Based Review.

Authors:  Adam S DeConde; Timothy L Smith
Journal:  Otolaryngol Clin North Am       Date:  2016-08       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.